0.2276

2.61% -0.0061

AIM ImmunoTech Inc (AIM)

Overview News Price History Discussions Forecast Stock Split

AIM ImmunoTech Inc stock is traded at $0.2276, with a volume of 8.45M. It is down -2.61% in the last 24 hours and down -13.46% over the past month. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen, a drug of macromolecular ribonucleic acid molecule for the treatment of chronic fatigue syndrome. It is also developing Ampligen for the treatment of Hepatitis B and HIV, as well as patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd. for the evaluation and discussion of business relationships concerning a COVID-19 therapeutic and vaccine. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Previous Close:

$0.2337

Open:

$0.2329

24h Volume:

8.45M

Relative Volume:

0.45

Market Cap:

$6.93M

Revenue:

$94,000

Net Income/Loss:

$-13.28M

P/E Ratio:

-0.0312

EPS:

-7.2965

Net Cash Flow:

$-11.67M

1W Performance:

-11.92%

1M Performance:

-13.46%

6M Performance:

-67.05%

1Y Performance:

-90.66%

1-Day Range:

$0.2266

$0.24

1-Week Range:

$0.2015

$0.3713

52-Week Range:

$0.1901

$2.977

AIM ImmunoTech Inc Stock (AIM) Company Profile

Name

AIM ImmunoTech Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

352 448 7797

Address

2117 SW Highway 484, Ocala, FL

Employee

Twitter

@AIMImmuno

Next Earnings Date

2026-08-13

Latest SEC Filings

AIM's Discussions on Twitter

Compare AIM vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AIM AIM ImmunoTech Inc	0.2276	7.70M	94,000	-13.28M	-11.67M	-7.2965
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

AIM ImmunoTech Inc Stock (AIM) Latest News

Aug 21, 2026

AIM ImmunoTech highlights pancreatic cancer program momentum - scanx.trade

Aug 21, 2026

Aug 20, 2026

AIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule — CEO Sees 'Significant Value-Inflection Period' Ahead - Stocktwits

Aug 20, 2026

AIM ImmunoTech (AIM) Stock Forecast & Analyst Ratings - Moomoo

Aug 20, 2026

AIM Maintained by Ascendiant Capital -- Price Target Lowered to $7.00 - GuruFocus

Aug 20, 2026

AIM (AIM) Earnings Snapshot: EPS Does Not Reach the Reported Estimate in the Latest Reading; After Earnings: The Share Price Adds 1.84% in the Latest SessionHigh Estimate Range - vinanet.vn

Aug 20, 2026

Aug 18, 2026

Why Did AIM Stock Plummet 35% Today? - Stocktwits

Aug 18, 2026

Aug 14, 2026

AIM Q2 2026 Earnings: Wider-than-Expected Loss Prompts Investor CautionFinal Results - vinanet.vn

Aug 14, 2026